Siga Technologies INC Loss Contingency Accrual, Period Increase (Decrease)
Siga Technologies INC (SIGA) reported Loss Contingency Accrual, Period Increase (Decrease) of $93.65 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-02.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency › Loss Contingency Accrual, Disclosures
us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease · last filed 2016-11-02
- 2016-09-30: Loss Contingency Accrual, Period Increase (Decrease) 9 month $93.65M.
- 2015-09-30: Loss Contingency Accrual, Period Increase (Decrease) 9 month $0.00.
| Period end | Loss Contingency Accrual, Period Increase (Decrease) 9 month |
|---|---|
| 2016-09-30 | $93.65M 10-Q · filed 2016-11-02 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |